Late-onset Alzheimer disease (AD) is the most common cause of dementia and the fifth leading cause of death in Americans older than 65 years.
1 The mechanisms underlying AD onset and progression remain largely unexplained. A study of twins
2 has demonstrated a significant role for genetics in late-onset AD, with heritability estimates of 60% to 80%. Until recently, the only genetic variant consistently shown to influence AD risk and age at onset was
APOE (OMIM 107741).
3 New findings from genome-wide association studies (GWASs) identified 3 additional loci conferring risk for AD:
CLU (OMIM 185430),
PICALM (OMIM 603025), and
CR1 (OMIM 120620).
4,5 Other promising loci were also reported in these GWASs but did not achieve
P values sufficient for genome-wide significance.